AusBiotech is honoured to announce the establishment of the Depaz Oration, an annual keynote to be introduced at the AusBiotech Conference in 2025 in ...

The company is banking on revenue from its Sanofi deal and vaccines in development ... Trump as U.S. president will be a boon ...

Sanofi will take the lead co-commercialization role for our ... The trial will enroll adults aged 65 years and older and is ...

Birds and humans have different types of receptors in their respiratory tract that flu viruses attach to, like a lock ...

La Corte also said Recordati would unveil its 2025 outlook in February, along with preliminary 2024 results, taking into account its recent acquisition from Sanofi (SASY.PA), opens ... Updated ago ...

While the inquiry gets most things right, as vaccine experts, we argue the government response should be broadened in three ...

Sanofi will also look to develop a COVID/Influenza ... and although Novavax secured approvals in the UK, Canada, Australia, Switzerland, Singapore and New Zealand, and thanks to a partnership ...

By using automated content recognition, Beatgrid can measure cross-platfrom ad exposure by individual as well as the ...

With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling ...

The S&P 500 fell 1.3 per cent on Friday, bringing its losses for the week to 2.1 per cent, its steepest drop since early September. The Nasdaq Composite fell 2.2 per cent on Friday and 3.1 per cent ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...